Finofab SRL
1.0 FTEFinofab reported total assets of 102,183 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Mar 2026), with 1 full-time equivalent.
The score of Finofab shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets -6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Finofab's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 57,130 € | ||||
| Equity | 37,215 € | ||||
| Cash | 81,267 € | ||||
| EBITDA | 84,725 € | ||||
| Total assets | 102,183 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Mar 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
- Year ended 31 Dec 2023filed on 05 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 27 Jul 2022
Finofab's financial analysis
- Solvency36.4%sector median: 49.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Finofab
Finofab's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0832.476.665
- VAT number
- BE0832476665
- Peppol
- Registered · 0208:0832476665 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Jan 2011
- Registered office
- 4051 Chaudfontaine
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 31 Mar 2026
- Activity
- Activities of head offices (NACE 70100)
Finofab (SRL) has been based in Chaudfontaine since 2011, active in: activities of head offices. For 2025, it reports a net profit of 57,130 € and equity of 37,215 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 36.4%, below the median of its sector (49.8%).
Companies similar to Finofab
Companies in the same business, of comparable size and area, outside its group.
- A BIG Consultancy Activities of head offices Knokke-Heist · balance sheet 108,829 €
- erla Activities of head offices Ghent · balance sheet 102,600 €
- Seicon Activities of head offices Roeselare · balance sheet 111,957 €
- VinEC Activities of head offices Wielsbeke · balance sheet 87,408 €
- JDK-Services Activities of head offices Zoersel · balance sheet 81,741 €
- JOBU Activities of head offices Roeselare · balance sheet 78,131 €
- De Vlieger Arnaud Activities of holding companies Zele · balance sheet 173,236 €
- Arthia Activities of head offices Bredene · balance sheet 75,520 €
Frequently asked questions about Finofab
What is the revenue of Finofab?
Finofab files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Finofab?
In Belgium, the VAT number is the company number prefixed with BE: BE0832476665 for Finofab, if the company is VAT-registered. Its company number (CBE) is 0832.476.665.
Where is the registered office of Finofab?
According to the CBE register, the registered office of Finofab is in 4051 Chaudfontaine.
What is the equity of Finofab?
At the close of the 2025 financial year, the equity of Finofab amounts to 37,215 €, a solvency of 36.4% of total assets.
How many people work at Finofab?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Finofab?
The register lists 1 active mandates at Finofab. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Finofab
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →